A unit of Insys Therapeutics Inc is set to plead guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to prescribe an addictive opioid medication.
from Reuters: U.S. https://reut.rs/2Ion0VH
0 comments:
Post a Comment